Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Study on AI-Powered Advanced Drug Discovery for Enhancing Privacy and Innovation in Healthcare
4
Zitationen
5
Autoren
2024
Jahr
Abstract
The chapter discusses the integration of artificial intelligence (AI) in healthcare, highlighting its potential in drug discovery and development. It emphasizes AI-driven methodologies for target identification, compound screening, and lead optimization, while ensuring data security and compliance with privacy regulations. It explores the use of machine learning algorithms like deep learning and reinforcement learning for predicting drug efficacy, safety profiles, and personalized treatment, while also discussing the ethical challenges of utilizing vast datasets and the importance of anonymization techniques. The chapter explores the use of AI in drug discovery, highlighting its impact on time and cost reduction. It suggests that by balancing innovation with strict privacy measures, AI can improve patient outcomes and streamline drug development processes. It provides insights into current trends and future directions.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.200 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.051 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.416 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.410 Zit.